Skip to main content

Milestone Pharmaceuticals Inc.

MIST
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001408443

No open-market purchases or sales by Milestone Pharmaceuticals Inc. insiders were filed in the last 90 days; 78 institutions reported holding it in 13F filings for Q2 2026, worth $66.4M in total; no superinvestor holds it.

Q2 2025 vs. Q1 2025

How the institutions holding Milestone Pharmaceuticals Inc. changed between Q1 2025 and Q2 2025.

All holders in Q2 2025All holders in Q1 2025

13F holders of MIST: Q1 2025 compared with Q2 2025
MeasureQ1 2025Q2 2025Change
Holders43430
Shares11.8M11.8M−6.56K (−0.1%)
Value$9.46M$22.9M+$13.5M (+142.3%)

New holders (10)

Institutions that held Milestone Pharmaceuticals Inc. at the end of Q2 2025 but not at the end of Q1 2025.

Institutions new to MIST in Q2 2025
InstitutionSharesValue% of portfolio
Goldman Sachs Group Inc119,449$231.7K0.00%
Cascades Capital Asset Management, LLC67,135$130.2K0.07%
Colony Group, LLC36,000$69.8K0.00%
Jane Street Group, LLC31,933$62.0K0.00%
Mercer Global Advisors Inc15,100$29.3K0.00%
Virtu Financial LLC14,761$29.0K0.00%
Bay Rivers Group14,321$27.8K0.01%
Mariner, LLC11,000$21.3K0.00%
Taylor Financial Group, Inc.10,000$19.4K0.01%
Oliver Lagore Vanvalin Investment Group100$800.00%

Sold out (10)

Institutions that held Milestone Pharmaceuticals Inc. at the end of Q1 2025 and filed for Q2 2025 without it.

Institutions that sold out of MIST in Q2 2025
InstitutionShares, Q1 2025Value, Q1 2025
Millennium Management LLC322,082$257.7K
Stonepine Capital Management, LLC250,000$200.0K
Two Sigma Advisers, LP76,000$60.8K
Simplex Trading, LLC40,636$32.0K
Dimensional Fund Advisors LP39,450$31.7K
BNP Paribas Arbitrage, SA26,023$20.8K
Clear Creek Financial Management, LLC10,500$8.40K
Integrated Wealth Concepts LLC10,000$8.00K
JPMorgan Chase & Co3,266$2.61K
Citigroup Inc2$2